Meta-analysis of comparison between self-expandable and balloon-expandable valves for patients having transcatheter aortic valve implantation.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  American Journal of Cardiology

• Publication date

  2015-06-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.amjcard.2015.03.015PMID 25890630
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Comparison of balloon-expandable vs self-expandable valves in patients undergoing transcatheter aortic valve replacement: the CHOICE randomized clinical trial.

  2014cited by this paper
• Impact of diabetes mellitus on early and midterm outcomes after transcatheter aortic valve implantation (from a multicenter registry).

  2014cited by this paper
• Aortic regurgitation after transcatheter aortic valve implantation with balloon- and self-expandable prostheses: a pooled analysis from a 2-center experience.

  2014cited by this paper
• Network meta-analyses: the "white whale" for cardiovascular specialists.

  2014cited by this paper
• Transcatheter aortic-valve replacement with a self-expanding prosthesis.

  2014cited by this paper
• Advanced chronic kidney disease in patients undergoing transcatheter aortic valve implantation: insights on clinical outcomes and prognostic markers from a large cohort of patients.

  2014cited by this paper
• Short-term clinical outcomes among patients undergoing transcatheter aortic valve implantation in Switzerland: the Swiss TAVI registry.

  2014cited by this paper
• Gender differences in patients undergoing TAVI: a multicentre study.

  2013cited by this paper
• 30 days and midterm outcomes of patients undergoing percutaneous replacement of aortic valve according to their renal function: a multicenter study.

  2013cited by this paper
• Inaccuracy of available surgical risk scores to predict outcomes after transcatheter aortic valve replacement

  2013cited by this paper
• Transfemoral aortic valve implantation in patients with an annulus dimension suitable for either the Edwards valve or the CoreValve.

  2013cited by this paper
• Comparison of hemodynamic performance of self-expandable CoreValve versus balloon-expandable Edwards SAPIEN aortic valves inserted by catheter for aortic stenosis.

  2013cited by this paper
• Numerical analysis of the radial force produced by the Medtronic-CoreValve and Edwards-SAPIEN after transcatheter aortic valve implantation (TAVI).

  2013cited by this paper
• Registry of transcatheter aortic-valve implantation in high-risk patients.

  2012cited by this paper
• Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document.

  2012cited by this paper
• Transcatheter aortic valve implantation with the Edwards SAPIEN versus the Medtronic CoreValve Revalving system devices: a multicenter collaborative study: the PRAGMATIC Plus Initiative (Pooled-RotterdAm-Milano-Toulouse In Collaboration).

  2012cited by this paper
• Valvular Heart Disease Aortic Regurgitation Index Defines Severity of Peri-Prosthetic Regurgitation and Predicts Outcome in Patients After Transcatheter Aortic Valve Implantation

  2012cited by this paper
• First-in-man use of a novel embolic protection device for patients undergoing transcatheter aortic valve implantation.

  2012cited by this paper
• Risk of stroke after transcatheter aortic valve implantation (TAVI): a meta-analysis of 10,037 published patients.

  2012cited by this paper
• Periprocedural and short-term outcomes of transfemoral transcatheter aortic valve implantation with the Sapien XT as compared with the Edwards Sapien valve.

  2011cited by this paper
• Long-term outcomes after transcatheter aortic valve implantation in high-risk patients with severe aortic stenosis: the U.K. TAVI (United Kingdom Transcatheter Aortic Valve Implantation) Registry.

  2011cited by this paper
• Standardized endpoint definitions for Transcatheter Aortic Valve Implantation clinical trials: a consensus report from the Valve Academic Research Consortium.

  2011cited by this paper
• Transcatheter Aortic-Valve Implantation for Aortic Stenosis in Patients Who Cannot Undergo Surgery

  2011cited by this paper
• Anatomic and procedural predictors of paravalvular aortic regurgitation after implantation of the Medtronic CoreValve bioprosthesis.

  2010cited by this paper
• Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium

  2010cited by this paper
• Percutaneous Aortic Valve Implantation Retrograde From the Femoral Artery

  2006cited by this paper
• Transapical Transcatheter Aortic Valve Implantation in Humans: Initial Clinical Experience

  2006cited by this paper
• Percutaneous Implantation of the CoreValve Self-Expanding Valve Prosthesis in High-Risk Patients With Aortic Valve Disease: The Siegburg First-in-Man Study

  2006cited by this paper
• Consensus Statement

  2004cited by this paper
• Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group.

  2000cited by this paper
• Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses.

  1999cited by this paper
• Improving the Quality of Reports of Meta-Analyses of Randomised Controlled Trials: The QUOROM Statement

  1999cited by this paper

• Comparison of Paravalvular Leak in SAPIEN 3 and EVOLUT PRO Valves in Transcatheter Aortic Valve Replacement: A Multicenter Registry.

  2023cites this paper
• Evaluation of Acquired Thrombocytopenia According to the Balloon-Expandable Versus Self-Expandable Valves in Patients Undergoing Transcatheter Aortic Valve Replacement

  2020cites this paper
• Safety and efficacy of self-expandable Evolut R vs. balloon-expandable Sapien 3 valves for transcatheter aortic valve implantation: A systematic review and meta-analysis

  2019cites this paper
• Edwards SAPIEN Versus Medtronic Aortic Bioprosthesis in Women Undergoing Transcatheter Aortic Valve Implantation (from the Win-TAVI Registry).

  2019cites this paper
• Comparison of paravalvular aortic leak characteristics in the Medtronic CoreValve versus Edwards Sapien Valve: Paravalvular aortic leak characteristics

  2018cites this paper
• Chapter 21 – Transcatheter Therapies for Structural Heart Diseases

  2018cites this paper
• Updates on transcatheter aortic valve replacement: Techniques, complications, outcome, and prognosis

  2018cites this paper
• Transcatheter aortic valve implantation: a revolution in the therapy of elderly and high-risk patients with severe aortic stenosis

  2017cites this paper
• Which is the best antiaggregant or anticoagulant therapy after TAVI? A propensity-matched analysis from the ITER registry. The management of DAPT after TAVI.

  2017cites this paper
• Year in review: transcatheter aortic valve replacement

  2016cites this paper
• Efficacy of the Perceval sutureless aortic valve bioprosthesis in the treatment of aortic valve stenosis

  2016cites this paper
• Evaluation of the Edwards SAPIEN 3 Transcatheter Valve For Aortic Stenosis

  2016cites this paper
• Early and Midterm Outcome of Propensity-Matched Intermediate-Risk Patients Aged ≥80 Years With Aortic Stenosis Undergoing Surgical or Transcatheter Aortic Valve Replacement (from the Italian Multicenter OBSERVANT Study).

  2016cites this paper
• Update on Transcatheter Aortic Valve Implantation

  2016cites this paper